DuPont Rejects Activist Trian's Board Picks
A proxy battle is breaking out between the board of DuPont Co. and activist investor Nelson Peltz's hedge fund Trian Fund Management LP, one of the chemical conglomerate's largest shareholders, with...To view the full article, register now.
Already a subscriber? Click here to view full article